U.S., Dec. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07265622) titled 'First-in-human Study of 7MW4911 in Patients With Advanced Solid Tumors' on Nov. 16.
Brief Summary: This is the first-in-human study of 7MW4911 in US patients, to investigate its prelimary safety and efficacy in patients with Advanced Solid Tumors.
Study Start Date: Nov. 12
Study Type: INTERVENTIONAL
Condition:
Solid Tumors
Intervention:
DRUG: 7MW4911
7MW4911 for IV infusion of various dose strengths administered
Recruitment Status: RECRUITING
Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd.
Disclaimer: Curated by HT Syndication....